Data Snapshot: Sep 06, 2026
$1M+

Aug-2026

Sales

Decline

Trend

6-Month

78

Product Count

SKUs

$34.06

Avg Price

-3.6%

YoY Sales Change

-3.1%

YoY Price Change

Papa & Barkley stands out as California's premier cannabis wellness brand, boasting the top spot in the market for topicals. Famed for their diverse product range, they specialize in CBD-rich balms and tinctures with varied CBD to THC ratios that cater to different therapeutic needs, with sleep and muscle pain relief among them. Also noteworthy is their commitment to transparency, readily providing vital product information for the consumer's scrutiny—evident in their comprehensive batch labels and accessible customer service.
Papa & Barkley

Where to Buy

Papa & Barkley is stocked at 668 licensed dispensaries across California and New York, 539 of them in California, with the deepest coverage in Los Angeles, Sacramento, San Diego, San Francisco, and Long Beach. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/1929.json?v=20260905
Papa & Barkley Sales

Market Insights Snapshot

Papa & Barkley Historical Sales by Category

In August 2026, Papa & Barkley’s mix was anchored by Topical at 51.30% share with a year-over-year decline of 6.00% and a month-over-month uptick of 0.26%, while Tincture & Sublingual held 31.74% share with a 2.59% YoY decline and 0.10% MoM increase. Edible expanded to 12.23% share with 22.72% YoY growth and 1.79% MoM growth, as Capsules sat at 4.66% share with a 24.06% YoY drop but a 12.64% MoM rebound; Concentrates were negligible at 0.07% share with a 59.29% YoY decline and a 54.80% MoM pullback. With average price down 3.07% YoY to $34.06 and overall brand sales down 3.64% YoY, the pattern implies stabilization in core formats with incremental substitution into lower-priced Edible, offsetting some pressure from aging Topical and Tincture & Sublingual cohorts.

The concurrent 0.26% MoM lift in Topical alongside a 12.64% MoM rise in Capsules—despite Topical’s 6.00% YoY and Capsules’ 24.06% YoY declines—indicates near-term promotional or assortment effects rather than durable demand shifts, especially as Concentrates contracted 54.80% MoM and 59.29% YoY. Edible’s 22.72% YoY growth at 12.23% share, combined with the 3.07% YoY price decrease and the brand’s 12.55% two-year sales decline, implies a repositioning toward accessible entry formats that can widen baskets while preserving Papa & Barkley’s lead rank of 1 in California Topical by leaning on cross-category trial to backfill softness in legacy wellness-oriented lines.

Aug-2026 Rank
Capsules
Edible
Tincture & Sublingual
Topical
9
29
1
1
3
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
51.3%
$34.14
-6.0%
+0.3%
Tincture & Sublingual
31.7%
$44.99
-2.6%
+0.1%
Edible
12.2%
$19.22
+22.7%
+1.8%
Capsules
4.7%
$51.99
-24.1%
+12.6%
Concentrates
0.1%
$51.16
-59.3%
-54.8%
Papa & Barkley

Competitive Landscape

Papa & Barkley holds rank #1 in CA Topical in August 2026, unchanged from #1 a year earlier, while maintaining #1 over the past three months and peaking at #1 in August 2026; in contrast, Mary's Medicinals is at #2 with a -10.3% year-over-year sales decline and Liquid Flower climbed from #6 to #4 with 60.5% year-over-year growth, indicating that stability at the top coexists with upward pressure from faster-growing challengers and implies Papa & Barkley’s flat rank trajectory masks rising competitive intensity that could compress future share if momentum shifts.

Papa & Barkley market ranking for CA Topical

Papa & Barkley

Notable Products

The sharpest movement in August 2026 was CBD/THC 1:3 THC Rich Releaf Balm (100mg CBD, 300mg THC, 50ml, 1.7oz) dropping -9.6% MoM while holding rank 2, contrasting with Sleep Releaf- CBD/CBN/THC 1:1:1 Berry Pomegranate Solventless Gummies 20-Pack (100mg CBN, 100mg CBD, 100mg THC) up 5.6% at rank 1; this split implies a tilt toward nighttime edible demand over legacy topical leadership. Within Topicals, CBD/THC 3:1 CBD Rich Releaf Balm (90mg CBD, 30mg THC, 15ml, 0.5oz) rose 13.8% to rank 9 even as the 15ml THC-rich balm slipped -1.4% at rank 6 and the body oil fell -4.5% at rank 5, suggesting format-size and ratio experimentation is nudging share toward lighter-dose SKUs. Edibles now claim two of the top ten while five of the top ten are Topicals, indicating concentration in relief-oriented formats but with growth momentum clustering in sleep-positioned gummies; the product mix points to Papa & Barkley reallocating emphasis from broad pain-relief topicals toward sleep and recovery use cases.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
Sleep Releaf- CBD/CBN/THC 1:1:1 Berry Pomegranate Solventless Gummies 20-Pack (100mg CBN, 100mg CBD, 100mg THC)
Edible
1
1
1
1
1
+5.6%
CBD/THC 1:3 THC Rich Releaf Balm (100mg CBD, 300mg THC, 50ml, 1.7oz)
Topical
2
2
2
2
2
-9.6%
CBD/THC 3:1 CBD Rich Releaf Balm (450mg CBD, 150mg THC, 50ml 1.7oz)
Topical
3
3
4
4
3
+3.6%
CBD/THC 3:1 CBD Rich Releaf Balm (135mg CBD, 33mg THC, 15ml)
Topical
5
5
3
5
4
-1.3%
CBD/THC 1:3 THC Rich Releaf Body Oil (100mg CBD, 300mg THC, 60ml)
Topical
4
4
6
3
5
-4.5%
CBD/THC 1:3 THC Rich Releaf Balm (30mg CBD, 90mg THC, 15ml, 0.5oz)
Topical
6
6
5
6
6
-1.4%
THC Releaf Oil Tincture (1000mg THC, 15ml)
Tincture & Sublingual
7
7
7
7
7
-2.8%
Sleep Releaf- CBD/CBG/THC 1:1:1 Pear Apple Recover Gummies 20-Pack (100mg CBD, 100mg CBG, 100mg THC)
Edible
9
9
8
8
8
-8.4%
CBD/THC 3:1 CBD Rich Releaf Balm (90mg CBD, 30mg THC, 15ml, 0.5oz)
Topical
10
10
9
10
9
+13.8%
CBD/THC 30:1 CBD Rich Releaf Tincture (435mg CBD, 15mg THC, 15ml)
Tincture & Sublingual
8
8
10
9
10
-3.1%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market